Spruce Biosciences Inc. (SPRB)
NASDAQ: SPRB
· Real-Time Price · USD
8.79
-0.16 (-1.79%)
At close: Jun 09, 2025, 3:57 PM
-1.79% (1D)
| Bid | 8.91 |
| Market Cap | 4.95M |
| Revenue (ttm) | 1.3M |
| Net Income (ttm) | -48.34M |
| EPS (ttm) | -99.75 |
| PE Ratio (ttm) | -0.09 |
| Forward PE | -13.31 |
| Analyst | Hold |
| Ask | 8.91 |
| Volume | 4,998 |
| Avg. Volume (20D) | 3,421 |
| Open | 8.72 |
| Previous Close | 8.95 |
| Day's Range | 8.06 - 9.40 |
| 52-Week Range | 0.10 - 45.60 |
| Beta | 2.44 |
About SPRB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SPRB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SPRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Spruce Biosciences Inc. is scheduled to release its earnings on
Nov 10, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-39.12%
Spruce Biosciences shares are trading lower after ...
Unlock content with
Pro Subscription
4 months ago
-58.02%
Spruce Biosciences shares are trading lower. The company announced a new corporate strategy and acquisition of tralesinidase alfa enzyme replacement therapy for the treatment of Sanfilippo Syndrome Type B.
